021-51111890
购物车（）
sales@molnova.cn
EG1
CAS No. 693241-54-2
EG1 ( —— )
产品货号. M24706 CAS No. 693241-54-2
EG1 是 Pax2 转录激活的新型特异性抑制剂，靶向 DNA 结合域并抑制胚胎肾脏发育。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥491 | 有现货 |
|
| 10MG | ￥791 | 有现货 |
|
| 25MG | ￥1283 | 有现货 |
|
| 50MG | ￥1925 | 有现货 |
|
| 100MG | ￥2601 | 有现货 |
|
| 200MG | ￥3519 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ￥436 | 有现货 |
|
生物学信息
-
产品名称EG1
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述EG1 是 Pax2 转录激活的新型特异性抑制剂，靶向 DNA 结合域并抑制胚胎肾脏发育。
-
产品描述EG1, a novel specific inhibitor of Pax2 transcription activation, targets the DNA binding domain and inhibits embryonic kidney development.
-
体外实验Cell Viability Assay Cell Line:Pax2 positive: a renal cell carcinoma line (RCC111), two ovarian carcinoma cell lines (TOV112D and ES-2); Pax2 negative: prostate cell lines 22Rv1, PC3 or the ovarian cancer cell line SK-OV-3 Concentration:0, 12.5, 25 μM Incubation Time:48 hours Result:All Pax2 positive cells exhibited a significant decrease in cell viability, whereas none of the Pax2 negative cells were affected.
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Pax2
-
研究领域——
-
适应症——
化学信息
-
CAS Number693241-54-2
-
分子量390.39
-
分子式C22H18N2O5
-
纯度>98% (HPLC)
-
溶解度DMSO:70mg/ml(179.31mM; need ultrasonic)
-
SMILESCOc(cccc1)c1C(Nc(cc1)ccc1C(Nc(cccc1)c1C(O)=O)=O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Smith CB, Phillips T, Smith TJ. Using the New ASCO Clinical Practice Guideline for Palliative Care Concurrent With Oncology Care Using the TEAM Approach. Am Soc Clin Oncol Educ Book. 2017;37:714-723. doi: 10.14694/EDBK_175474. PubMed PMID: 28561696.
产品手册
关联产品
-
2,3-Dihydro-3-hydrox...
2-(3-Hydroxy-2-oxoindolin-3-yl)-acetic acid (compound 29) 是一种在啤酒花苞片中发现的天然多酚化合物。
-
Fmoc-N-Me-Leu-OH
Fmoc-N-Me-Leu-OH 是一种 N-Fmoc-N-甲基氨基酸，可用于肽偶联反应。
-
AK301
AK301 is a potent and selective inhibitor of tubulin polymerization and an effective sensitizer of cancer cells to apoptotic ligands (EC50 < 200 nM). Colon cancer cells arrested in mitosis with AK301 readily underwent a p53-dependent apoptosis following compound withdrawal and arrest release.
